Opko Inc. has acquired Cytochroma Inc.

Target Company Name:
Country:
Advisory:
Sector:
Partner:
Cytochroma Inc.
Canada
Advisor
Healthcare & Pharmaceuticals
Crosbie & Company Inc.

Advised the Board and provided a fairness opinion relating to Opko Health's purchase of 100% of the shares of Cytochroma

Cytochroma Inc.
Opko Inc.
Advised the Board of Cytochroma and provided a fairness opinion relating to Opko's purchase the company
logo
Advisor :
Crosbie & Company Inc.

Experts who worked on this transaction

Colin Walker

Colin Walker

Managing Director at Crosbie & Company Inc.

Richard Betsalel

Richard Betsalel

Managing Director at Crosbie & Company Inc.

Relevant transactions

Transactions
Project Amygdala
Private Equity
Sale of mental health services provider for high-acuity individuals in the UK
logo
Advisor to the seller :
Cooper Parry Corporate Finance
Genbio
Private Investors
Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors
logo
Advisor to the seller :
RIóN
icotec
MVM Partners
icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM
logo
Advisor
Alpha Source Group
Probo Medical
Alpha Source Group, a portfolio company of Baird Capital, acquired by Probo Medical.
logo
Advisor to the seller :
Brown Gibbons Lang & Company

REACH Cross-Border Mergers & Acquisitions is a worldwide partnership of 24 M&A advisory firms operating across 30 countries.

REACH Cross-Border Mergers & Acquisitions Logo with tagline Terms & Conditions
Privacy Policy

© 2024 REACH Cross-Border Mergers & Acquisitions